Table II.
Non-susceptible percentages* of Gram-negative bacilli isolated from all specimen (except faeces)
| Antimicrobial agent | E. coli | K. pneumoniae | A. baumannii | P. aeruginosa |
|---|---|---|---|---|
| Amikacin | 18.6 | 48.5 | 77.8 | 31.2 |
| Gentamicin | - | - | - | 39.3 |
| Ciprofloxacin/levofloxacin† | 76.3 | 65.8 | 73.2 | 41.4 |
| Cefotaxime/cefepime† | 80 | 77.2 | 87.1 | 37.8 |
| Ceftazadime | 76.6 | 73.1 | 87 | 34.7 |
| Imipenem | 22.5 | 42.7 | 82.2 | 29.6 |
| Meropenem | 26.9 | 49.3 | 78.3 | 31.3 |
| Piperacillin-tazobactam | 38.6 | 57.5 | 83 | 30.1 |
| Colistin | 1.1 | 8.8 | - | 3.2 |
*Non-susceptibility data include both I and R data. †Ciprofloxacin and cefotaxime tested in E. coli and K. pneumoniae. Levofloxacin and cefepime tested in A. baumannii and P. aeruginosa. K. pneumoniae, Klebsiella pneumoniae; A. baumannii, Acinetobacter baumannii; P. aeruginosa, Pseudomonas aeruginosa; I, intermediate; R, resistant; E. coli, Escherichia coli Source: ICMR-AMRSN data 2016-2018